Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

18

Revenue 2017

Takeda

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Takeda's 2013 sales performance.

Takeda

Regeneron and Teva close gap on rivals with NGF pain drug

Regeneron and Teva close gap on rivals with NGF pain drug

Amgen was also developing an NGF inhibitor called fulranumab – formerly partnered with Johnson &Johnson and Takeda – but the collaborators handed back rights in 2016 and the drug  no longer features in

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress The Cambridge, UK-based biotech says the new development marks a successful delivery of a “highly diverse panel”of functional Humabody leads against Takeda’s selected targets. ... Our highly productive relationship draws together Takeda’s deep

Immunology keeps Shire figures solid as Takeda takeover nears

Immunology keeps Shire figures solid as Takeda takeover nears Immunology keeps Shire figures solid as Takeda takeover nears. Shire’s sales increased by 6% to $3.81bn. ... Faced with a steep decline in its own profits in the last quarter, Takeda will have been looking for good numbers from acquisition target Shire

AbbVie’s blockbuster-in-waiting for endometriosis gets FDA nod

AbbVie’s blockbuster-in-waiting for endometriosis gets FDA nod AbbVie has a window of opportunity to grow its product before a rival therapy from Takeda and Myovant can reach the market.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics